Abstract
The bipolar disorders are a group of severe mood disorders that together afflict about 3% of the global population. They are characterized by the presence of both manic or hypomanic episodes and depressive episodes. They are divided into type I disorder, which is defined by the occurrence of severe manic episodes; type II disorder in which the depressive episode occurs with hypomania but not mania; and cyclothymia, in which subsyndromal hypomanic and depressions are present. These disorders are highly familial but environmental factors are also important. Comorbidity with medical and psychiatric conditions, particularly alcohol use disorder, is common. Treatments include the use of mood stabilizers such as lithium and some anticonvulsants. The use of agents such as antipsychotics and antidepressants are common. Prognosis is guarded for many, but for some patients there is restitutio ad integrum between episodes, and some are highly creative and productive.
This chapter is an update from the 4th edition. Previous edition author was Rif S. El-Mallakh
Similar content being viewed by others
References
Al Risi, K., Al Maqbali, M., Asiri, W. A., Al & Sinawi, H. (2018). Rate of Tobacco Smoking Among Psychiatric Outpatients Attending a Tertiary Care Hospital in Oman: A Cross-sectional Study. Oman Med J, 33(3), 224–228. https://doi.org/10.5001/omj.2018.41
Ali Z, El-Mallakh RS (2021) Lithium nephropathy and renal microcysts. Current Psychiatry (in press).
Angst, J., Ajdacic-Gross, V., & Rössler, W. (2020). Bipolar disorders in ICD-11: Current status and strengths. International Journal of Bipolar Disorers, 8, 3.
Baldessarini, R. J., Tondo, L., & Vazquez, G. H. (2019). Pharmacologic treatment of adult bipolar disorder. Bipolar Disorders, 24(2), 198–217.
Ball, J. R., Mitchell, P. B., & Corry, J. C., et al. (2006). A randomized controlled trial of cognitive therapy for bipolar disorder: focus on long-term change. Journal of Clinical Psychiatry, 67, 277–286.
Bauer, M. S., McBride, L., & Williford, W. O., et al. (2006a). Collaborative care for bipolar disorder. Part I: Intervention and implementation in a randomized effectiveness trial. Psychiatric Services, 57, 927–936.
Bauer, M. S., McBride, L., & Williford, W. O., et al. (2006b). Collaborative care for bipolar disorder. Part II: Impact on clinical outcome, function, and costs. Psychiatric Services, 57, 937–945.
Belmaker, R. H. (2004). Bipolar disorder. New England Journal of Medicine, 351(5), 476–485.
Belmaker, R. H. (2007). Treatment of bipolar depression. New England Journal of Medicine., 356(17), 1771–1773.
Belmaker, R. H., & Agam, G. (2008). Major depressive disorder. N Engl J Med, 358(1), 55–68. https://doi.org/10.1056/NEJMra073096. PMID: 18172175.
Belvederi Murri, M., Prestia, D., Mondelli, V., et al. (2016). The HPA axis in bipolar disorder: Systematic review and meta-analysis. Psychoneuroendocrinology, 63, 327–342.
Berk, L., Hallam, K. T., Colom, F., Vieta, E., Hasty, M., Macneil, C., & Berk, M. (2010). Enhancing medication adherence in patients with bipolar disorder. Hum Psychopharmacol, 25(1), 1–16. https://doi.org/10.1002/hup.1081. Erratum in: Hum Psychopharmacol. 2010 Mar;25(2):192.
Bhardwaj, R., Chakrabarti, S., & Mittal, B. R., et al. (2010). A single photon emission computerized tomography (SPECT) study of regional cerebral blood flow in bipolar disorder. World Journal of Biological Psychiatry, 11(2 Pt 2), 334–343.
Birmaher, B., Axelson, D., Goldstein, B., et al. (2009). Four-year longitudinal course of children and adolescents with bipolar spectrum disorders: The course and outcome of bipolar youth (COBY) study. The American Journal of Psychiatry, 166(7), 795–804.
Bo, Q., Mao, Z., Li, X., et al. (2017). Use of the MATRICS consensus cognitive battery (MCCB) to evaluate cognitive deficits in bipolar disorder: A systematic review and meta-analysis. PLoS One, 12(4).
Bolton, J. M., Robinson, J., & Sareen, J. (2009). Self-medication of mood disorders with alcohol and drugs in the National Epidemiologic Survey on alcohol and related conditions. Journal of Affective Disorders, 115(3), 367–375.
Carvalho, A. F., Firth, J., & Vieta, E. (2020). Bipolar disorder. New England Journal of Medicine, 383(1), 58–66.
Cattarinussi, G., Di Giorgio, A., Wolf, R. C., et al. (2019). Neural signatures of the risk for bipolar disorder: A meta-analysis of structural and functional neuroimaging studies. Bipolar Disorders, 21(3), 215–227.
Chandrasekaran, V., Brennan-Olsen, S. L., Stuart, A. L., et al. (2019). Bipolar disorder and bone health: A systematic review. Journal of Affective Disorders, 249, 262–269.
Clarkin, J. F., Glick, I., & Haas, G., et al. (1990). A randomized clinical trial of inpatient family intervention. V. results for affective disorders. Journal of Affective Disorders, 18, 17–28.
Clarkin, J. F., Carpenter, D., & Hull, J., et al. (1998). Effects of psychoeducational intervention for married patients with bipolar disorder and their spouses. Psychiatric Services, 49, 531–533.
Cochran, S. D. (1984). Preventing medical noncompliance in the outpatient treatment of bipolar affective disorders. Journal of Consulting and Clinical Psychology, 52, 873–878.
Colom, F., Vieta, E., & Martinez-Aran, A., et al. (2003a). A randomized trial on the efficacy of group psychoeducation in the prophylaxis of recurrences in bipolar patients whose disease is in remission. Archives of General Psychiatry, 60, 402–407.
Colom, F., Vieta, E., & Reinares, M., et al. (2003b). Psychoeducation efficacy in bipolar disorders: beyond compliance enhancement. Journal of Clinical Psychiatry, 64, 1101–1105.
Cotovio, G., Talmasov, D., Barahona-Corea, B., et al. (2020). Mapping mania symptoms based on focal brain damage. Journal of Clinical Investigation., 130(10), 5209–5222.
DelBello, M. P., Goldman. R., & Phillips. D., et al. (2017). Efficacy and safety of lurasidone in children and adolescents with bipolar I depression: A double-blind, placebo-controlled study. Journal of the American Academy of Child and Adolescent Psychiatry, 56(12), 1015–1025. https://doi.org/10.1016/j.jaac.2017.10.006
Demissie, M., Hanlon, C., Birhane, R., et al. (2018). Psychological interventions for bipolar disorder in low- and middle-income countries: Systematic review. BJPsych Open, 4(5), 375–384.
El-Mallakh, P. (1998). Treatment models for clients with co-occurring addictive and mental disorders. Archives of Psychiatric Nursing, 12(2), 71–80.
El-Mallakh, R. S., & Huff, M. O. (2001). Mood stabilizers and ion regulation. Harvard Review of Psychiatry, 9(1), 23–32.
El-Mallakh, R. S., Ghaemi, S. N., Sagduyu, K., et al. (2008). Antidepressant-associated chronic irritable dysphoria (ACID) in STEP-BD patients. Journal of Affective Disorders, 111(2–3), 372–377.
El-Mallakh RS, Vöhringer PA, Ostacher MM, et al. (2015) Antidepressants worsen rapid-cycling course in bipolar depression: a STEP-BD randomized clinical trial. Journal of Affective Disorders, 184, 318–321. [published correction appears in Journal of Affective Disorders 2016 190, 895].
Ferrer, A., Costas, J., Gratacos, M., et al. (2020). Clock gene polygenic risk score and seasonality in major depressive disorder and bipolar disorder. Genes, Brain and Behavior, 19(8), e12683.
Findling, R. L., McNamara, N. K., & Pavuluri, M., et al. (2019). Lithium for the maintenance treatment of bipolar I disorder: A double-blind, placebo-controlled discontinuation study. Journal of the American Academy of Child and Adolescent Psychiatry, 58(2), 287–296.e4. https://doi.org/10.1016/j.jaac.2018.07.901
Fornaro, M., Orsolini, L., Marini, S., et al. (2016). The prevalence and predictors of bipolar and borderline personality disorders comorbidity: Systematic review and meta-analysis. Journal of Affective Disorders, 195, 105–118.
Fornaro, M., Carvlho, A. F., Fusco, A., et al. (2020). The concept and management of acute episodes of treatment-resistant bipolar disorder: A systematic review and exploratory meta-analysis of randomized controlled trials. Journal of Affective Disorders, 276, 970–983.
Frank, E., Swartz, H., & Mallinger, A. G., et al. (1999). Adjunctive psychotherapy for bipolar disorder: effects of changing treatment modality. Journal of Abnormal Psychology, 108, 579–587.
Frank, E., Kupfer, D. J., & Thase, M. E., et al. (2005). Two-year outcomes for interpersonal and social rhythm therapy in individuals with bipolar I disorder. Archives of General Psychiatry, 62, 996–1004.
Galling, B., Garcia, M. A., & Osuchukwu, U., et al. (2015). Safety and tolerability of antipsychotic-mood stabilizer co-treatment in the management of acute bipolar disorder: results from a systematic review and exploratory meta-analysis. Expert Opinion in Drug Safety, 14(8), 1181–1199. https://doi.org/10.1517/14740338.2015.1053457
Gao, Y., Lei, Z., Lu, C., Roisen, F. J., & El-Mallakh, R. S. (2010). Effect of ionic stress on apoptosis and the expression of TRPM2 in human olfactory neuroepithelial-derived progenitors. World Journal of Biological Psychiatry, 11(8), 972–984.
Gao, Y., Lohano, K., Delamere, N. A., Lei, Z., & El-Mallakh, R. S. (2019). Ethanol normalizes glutamate-induced elevation of intracellular sodium in olfactory neuroepithelial progenitors from subjects with bipolar illness but not nonbipolar controls: Biologic evidence for the self-medication hypothesis. Bipolar Disorders, 21(2), 179–181.
Ghaemi, S. N., Ostacher, M. M., El-Mallakh, R. S., et al. (2010). Antidepressant discontinuation in bipolar depression: A systematic treatment enhancement program for bipolar disorder (STEP-BD) randomized clinical trial of long-term effectiveness and safety. Journal of Clinical Psychiatry, 71(4), 372–380.
Gonul, A. S., Coburn, K., & Kula, M. (2009). Cerebral blood flow, metabolic, receptor, and transporter changes in bipolar disorder: The role of PET and SPECT studies. International Review of Psychiatry, 21(4), 323–335.
Goodwin, F. K., & Jamison, K. R. (2007). Depressive illness: Bipolar disorders and recurrent depression (2nd ed., p. 2007). Oxford University Press.
Grant, B. F., Stinson, F. S., Hasin, D. S., et al. (2005). Prevalence, correlates, and comorbidity of bipolar I disorder and axis I and II disorders: Results from the National Epidemiologic Survey on alcohol and related conditions. Journal of Clinical Psychiatry, 66(10), 1205–1215.
Grant, B. F., Chou, S. P., Goldstein, R. B., et al. (2008). Prevalence, correlates, disability, and comorbidity of DSM-IV borderline personality disorder: Results from the wave 2 National Epidemiologic Survey on alcohol and related conditions. Journal of Clinical Psychiatry, 69(4), 533–545.
Haggarty, S. J., Karmacharya, R., & Perlis, R. H. (2021). Advances toward precision medicine for bipolar disorder: Mechanisms & molecules. Molecular Psychiatry, 26(1), 168–185.
Hajek, T., Bauer, M., Simhandl, C., et al. (2014). Neuroprotective effect of lithium on hippocampal volumes in bipolar disorder independent of long-term treatment response. Psychological Medicine, 44(3), 507–517.
He, H., Hu, C., Ren, Z., et al. (2020). Trends in the incidence and DALYs of bipolar disorder at global, regional, and national levels: Results from the global burden of disease study 2017. Journal of Psychiatric Research, 125, 96–105.
Healy, D. (2008). Mania: A short history of bipolar disorder. Johns Hopkins University Press.
Hernandez-Gomez, A., Andrade-Gonzalez, N., Lahera, G., et al. (2021). Recommendations for the care of patients with bipolar disorder during the COVID-19 pandemic. Journal of Affective Disorders, 297, 117–121.
Hodes, A., Rosen, H., Cohen-Ben Ami, H., & Lichtstein, D. (2019). Na+, K+-ATPase α3 isoform in frontal cortex GABAergic neurons in psychiatric diseases. Journal of Psychiatric Research, 115, 21–28.
Jackson, D., Kolikonda, M. K., Yeruva, R. R., & El-Mallakh, R. S. (2018). Sexual behavior in patients with bipolar illness. Annals of Clinical Psychiatry, 30(4), 289–295.
Jauhar, S., Nour, M. M., Veronese, M., et al. (2017). A test of the transdiagnostic dopamine hypothesis of psychosis using positron emission tomographic imaging in bipolar affective disorder and schizophrenia. JAMA Psychiatry, 74(12), 1206–1213.
Johnson, S. L. (2005). Life events in bipolar disorder: towards more specific models. Clinical Psychology Review, 25, 1008–1027.
Joshi, A., Bow, A., & Agius, M. (2019). Pharmacological Therapies in Bipolar Disorder: a Review of Current Treatment Options. Psychiatria Danubina, 31(Suppl 3), 595–603.
Karow, A., Brettschneider, C., et al. (2020). Better care for less money: Cost-effectiveness of integrated care in multi-episode patients with severe psychosis. Acta Psychiatrica Scandinavica, 141(3), 221–230.
Kessing, L. V., Vradi, E., & Andersen, P. K. (2015). Life expectancy in bipolar disorder. Bipolar Disorders, 17(5), 543–548. https://doi.org/10.1111/bdi.12296
Kishi T, Ikuta T, Matsuda Y, et al. (2020a). Mood stabilizers and/or antipsychotics for bipolar disorder in the maintenance phase: a systematic review and network meta-analysis of randomized controlled trials. Molecular Psychiatry. In press.
Kishi T, Matsuda Y, Sakuma K, et al. (2020b). Recurrence rates in stable bipolar disorder patients after drug discontinuation v. drug maintenance: a systematic review and meta-analysis. Psychol Med. In press.
Kraiss, J. T., Wijnen, B., Kupka, R. W., Bohlmeijer, E. T., & Lokkerbol, J. (2020). Economic evaluations of non-pharmacological interventions and cost-of-illness studies in bipolar disorder: A systematic review. Journal of Affective Disorders, 276, 388–401.
Kreinin, A., Novitski, D., Rabinowitz, D., Weizman, A., & Grinshpoon, A. (2012). Association between tobacco smoking and bipolar affective disorder: clinical, epidemiological, cross-sectional, retrospective study in outpatients. Compr Psychiatry, 53(3), 269–74. https://doi.org/10.1016/j.comppsych.2011.04.063
Lam, D. H., Bright, J., & Jones, S., et al. (2000). Cognitive therapy for bipolar illness – a pilot study of relapse prevention. Cognitive Therapy and Research, 24, 503–520.
Lam, D. H., Watkins, E. R., & Hayward, P., et al. (2003). A randomized controlled study of cognitive therapy for relapse prevention for bipolar affective disorder. Outcome of the first year. Archives of General Psychiatry, 60, 145–152.
Lam, D. H., Hayward, P., & Watkins, E. R., et al. (2005a). Relapse prevention in patients with bipolar disorder; cognitive therapy outcome after 2 years. American Journal of Psychiatry, 162, 324–329.
Lam, D. H., McCrone, P., & Wright, K., et al. (2005b). Cost-effectiveness of relapse prevention cognitive therapy for bipolar disorder: 30-month study. British Journal of Psychiatry, 186, 500–506.
Lee, Y., Brietzke, E., Cao, B., et al. (2020). Development and implementation of guidelines for the management of depression: A systematic review. Bulletin of the World Health Organization, 98, 683–697H.
Lim, C. S., Baldessarini, R. J., Vieta, E., et al. (2013). Longitudinal neuroimaging and neuropsychological changes in bipolar disorder patients: Review of the evidence. Neuroscience and Biobehavioral Reviews, 37(3), 418–435.
Luykx, J. J., Giuliani, F., Giuliani, G., et al. (2019). Coding and non-coding RNA abnormalities in bipolar disorder. Genes (Basel), 10(11), 946.
Mack, A., Gao, Y., Kakar, S., et al. (2019). Review of animal models of bipolar disorder that alter ion regulation. Neuroscience and Biobehavioral Reviews, 107, 208–214.
MacQueen, G. J., Hajek, T., & Alda, M. (2005). The phenotypes of bipolar disorder: Relevance for genetic investigations. Molecular Psychiatry, 10, 811–826.
Madden, J. M., Araujo-Lane, C., Foxworth, P., et al. (2020). Experiences of health care costs among people with employer-sponsored insurance and bipolar disorder. Journal of Affective Disorders, 281, 41–50.
Malhi, G. S., & Berk, M. (2012). Is the safety of lithium no longer in the balance? Lancet, 379, 690–692.
McIntyre, R. S., Patel, M. D., Masand, P. S., et al. (2021). The rapid mood screener (RMS): A novel and pragmatic screener for bipolar I disorder. Current Medical Research and Opinion, 37(1), 135–144.
McKnight, R. F., Adida, M., Budge, K., et al. (2012). Lithium toxicity profile: A systematic review and meta-analysis. Lancet, 379, 721–728.
Meltzer-Brody, S., Colquhoun, H., Riesenberg, R., et al. (2018). Brexanolone injection in post-partum depression: Two multicentre, double-blind, randomised, placebo-controlled, phase 3 trials. Lancet, 392(10152), 1058–1070.
Merikangas KR, Akiskal HS, Angst J, et al. (2007) Lifetime and 12-month prevalence of bipolar spectrum disorder in the National Comorbidity Survey Replication. Archives of General Psychiatry, 64(5), 543–552. (Erratum in Archives of General Psychiatry, 64(9), 1039).
Miklowitz, D. J., Simoneau, T. L., & George, E. L., et al. (2000). Family-focused treatment of bipolar disorder: 1-year effects of a psychoeducational program in conjunction with pharmacotherapy. Biological Psychiatry, 48, 582–592.
Miklowitz, D. J., George, E. L., & Richards, J. A., et al. (2003). A randomized study of family-focused psychoeducation and pharmacotherapy in the outpatient management of bipolar disorder. Archives of General Psychiatry, 60, 904–912.
Miller, J. N., & Black, D. W. (2020). Bipolar disorder and suicide: A review. Current Psychiatry Reports, 22(2), 6.
Miller, I. W., Solomon, D. A., & Ryan, C. E., et al. (2004). Does adjunctive family therapy enhance recovery from bipolar I mood episodes? Journal of Affective Disorders, 82, 431–436.
Minassian, A., Young, J. W., Geyer, M. A., et al. (2018). The COMT Val158Met polymorphism and exploratory behavior in bipolar mania. Molecular Neuropsychiatry, 3(3), 151–156.
Nicholas, J., Boydell, K., & Christensen, H. (2017). Beyond symptom monitoring: Consumer needs for bipolar disorder self-management using smartphones. European Psychiatry, 44, 210–216.
Oedegaard, K. J., Alda, M., Anand, A., et al. (2016). The pharmacogenomics of bipolar disorder study (PGBD): Identification of genes for lithium response in a prospective sample. BMC Psychiatry, 16, 129.
Okbay, A., Beauchamp, J. P., Fontana, M. A., et al. (2016). Genome-wide association study identifies 74 loci associated with educational attainment. Nature, 26(533 [7604]), 539–542.
Pan, Y. J., Yeh, L. L., Chen, Y. C., et al. (2016). Hospital treatment, mortality and healthcare costs in relation to socioeconomic status among people with bipolar affective disorder. BJPsych Open, 2(1), 10–17.
Parmentier, T., & Sienaert, P. (2018). The use of triiodothyronine (T3) in the treatment of bipolar depression: A review of the literature. Journal of Affective Disorders, 229, 410–414.
Perry, A., Tarrier, N., & Morriss, R., et al. (1999). Randomized controlled trial of efficacy of teaching patients with bipolar disorder to identify early symptoms of relapse and obtain treatment. BMJ, 318, 149–153.
Popovic, D., Reinares, M., Goikolea, J. M., et al. (2012). Polarity index of pharmacological agents used for maintenance treatment of bipolar disorder. European Neuropsychopharmacology, 22(5), 339–346.
Post, R. M. (2021). The kindling/sensitization model and early life stress. Current Topics in Behavioral Neuroscience, 48, 255–275.
Post, R. M., Leverich, G. S., Altshuler, L. L., et al. (2011). Differential clinical characteristics, medication usage, and treatment response of bipolar disorder in the US versus The Netherlands and Germany. International Clinical Psychopharmacology, 26(2), 96–106.
Post, R. M., Altshuler, L. L., Kupka, R., et al. (2020). More assortative mating in US compared to European parents and spouses of patients with bipolar disorder: Implications for psychiatric illness in the offspring. European Archives of Psychiatry and Clinical Neuroscience, 270(2), 237–245.
Raja, M., & Raja, S. (2014). Lithium treatment in elderly patients affected by mood disorders. Rivista di Psichiatria, 49(4), 180–182. https://doi.org/10.1708/1600.17456
Rea, M. M., Tompson, M. C., & Miklowitz, D. J., et al. (2003). Family-focused treatment versus individual treatment for bipolar disorder: results of a randomized clinical trial. Journal of Consulting and Clinical Psychology, 3, 482–492.
Ren, H., Guan, L., Zhao, L., et al. (2018). Contribution of genes in the GABAergic pathway to bipolar disorder and its executive function deficit in the Chinese Han population. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 177(1), 50–67.
Rhee, T. G., Olfson, M., Nierenberg, A. A., et al. (2020). 20-year trends in the pharmacologic treatment of bipolar disorder by psychiatrists in outpatient care settings. American Journal of Psychiatry, 177(8), 706–715.
Rush, A. J., Jr., First, M. B., & Blacker, D. (2007). Handbook of psychiatric measures (2nd ed.). American Psychiatric Press.
Saha, S., Lim, C. C. W., Cannon, D. L., et al. (2020). Co-morbidity between mood and anxiety disorders: A systematic review and meta-analysis. Depression and Anxiety, 38(3), 286–306.
Saiyad, M., & El-Mallakh, R. S. (2012). Smoking is associated with greater symptom load in bipolar disorder patients. Ann Clin Psychiatry, 24(4), 305–9.
Santos, R., Linker, S. B., Stern, S., et al. (2021). Deficient LEF1 expression is associated with lithium resistance and hyperexcitability in neurons derived from bipolar disorder patients. Molecular Psychiatry, 26(6), 2440–2456.
Saraf, G., Moazen-Zadeh, E., Pinto, J. V., et al. (2021). Early intervention for people at high risk of developing bipolar disorder: A systematic review of clinical trials. Lancet Psychiatry, 8(1), 64–75.
Schoeyen, H. K., Birkenaes, A. B., Vaaler, A. E., et al. (2011). Bipolar disorder patients have similar levels of education but lower socio-economic status than the general population. Journal of Affective Disorders, 129(1–3), 68–74.
Scott, J., Garland, A., & Moorhead, S. (2001). A pilot study of cognitive therapy in bipolar disorders. Psychological Medicine, 31, 459–467.
Scott, J., Paykel, E., Morriss, R., et al. (2006). Cognitive-behavioral therapy for bipolar disorder. British Journal of Psychiatry, 188, 488–489.
Sheehan, D. V., Harnett-Sheehan, K., & Hidalgo, R. B., et al. (2013). Randomized, placebo-controlled trial of quetiapine XR and divalproex ER monotherapies in the treatment of the anxious bipolar patient. Journal of Affective Disorders, 145(1), 83–94.
Shobassy, A. (2021). Elderly bipolar disorder. Current Psychiatry Reports, 23(2), 5.
Simon, G. E., Ludman, E. J., & Unützer, J., et al. (2005). Effectiveness of a population-based care program for people with bipolar disorder. Psychological Medicine, 35, 13–24.
Simon, G. E., Ludman, E. J., & Bauer, M. S., et al. (2006). Long-term effectiveness and cost of a systematic care management program for bipolar disorder. Archives of General Psychiatry, 63, 500–508.
Singh, N., Serres, F., Toker, L., et al. (2020). Effects of the putative lithium mimetic ebselen on pilocarpine-induced neural activity. European Journal of Pharmacology, 883, 173377.
Sleem, A., & El-Mallakh, R. S. (2021). Advances in the psychopharmacotherapy of bipolar disorder type I. Expert Opinion in Pharmacotherapy, 22(10), 1267–1290.
Stern, S., Sarkar, A., Stern, T., et al. (2020a). Mechanisms underlying the hyperexcitability of CA3 and dentate gyrus hippocampal neurons derived from bipolar disorder patients. Biological Psychiatry, 88(2), 139–149.
Stern, S., Sarkar, A., Galor, D., et al. (2020b). A physiological instability displayed in hippocampal neurons derived from lithium non-responsive bipolar disorder patients. Biological Psychiatry, 88(2), 150–158.
Suppes, T., Vieta, E., Gustafsson, U., et al. (2013). Maintenance treatment with quetiapine when combined with either lithium or divalproex in bipolar I disorder: Analysis of two large randomized, placebo-controlled trials. Depression and Anxiety, 30(11), 1089–1098.
Teh, W. L., Abdin, E., Vaingankar, J., et al. (2020). Prevalence and correlates of bipolar spectrum disorders in Singapore: Results from the 2016 Singapore mental health study (SMHS 2016). Journal of Affective Disorders, 274, 339–346.
Velosa, J., Delgado, A., Finger, E., et al. (2020). Risk of dementia in bipolar disorder and the interplay of lithium: A systematic review and meta-analyses. Acta Psychiatrica Scandinavica, 141(6), 510–521.
Vieta, E., Salagre, E., Grande, I., et al. (2018a). Early intervention in bipolar disorder. American Journal of Psychiatry, 175(5), 411–426.
Vieta, E., Berk, M., Schulze, T. G., et al. (2018b). Bipolar disorders. Nature Reviews Disease Primers, 4, 18008.
Vo, D., & Dunner, D. L. (2003). Treatment-resistant bipolar disorder: a comparison of rapid cyclers and nonrapid cyclers. CNS Spectrums, 8(12), 948–952. https://doi.org/10.1017/s1092852900028716
Wang, K., Varma, D. S., & Prosperi, M. (2018). A systematic review of the effectiveness of mobile apps for monitoring and management of mental health symptoms or disorders. Journal of Psychiatric Research, 107, 73–78.
Weiss, R. D., Griffin, M. L., & Kolodziej, M. E., et al. (2007). A randomized trial of integrated group therapy versus group drug counseling for patients with bipolar disorder and substance dependence. American Journal of Psychiatry, 164, 100–107.
Winokur, G., Clayton, P. J., & Reich, T. (1969). Manic-depressive illness. CV Mosby.
Young, A. H., & Juruena, M. F. (2021). The neurobiology of bipolar disorder. Current Topics in Behavioral Neurosciences, 48, 1–20.
Young, A. H., Rigney, U., Shaw, S., Emmas, C., & Thompson, J. M. (2011). Annual cost of managing bipolar disorder to the UK healthcare system. J Affect Disord, 133(3), 450–6. https://doi.org/10.1016/j.jad.2011.06.016
Zhang, Y. S., Rao, W. W., Zeng, L. N., et al. (2020). Prevalence and correlates of bipolar disorder in the adult population of Hebei province, China. Journal of Affective Disorders, 263, 129–133.
Zhang, C., Xiao, X., Li, T., et al. (2021). Translational genomics and beyond in bipolar disorder. Molecular Psychiatry, 26(1), 186–202.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Section Editor information
Rights and permissions
Copyright information
© 2023 Springer Nature Switzerland AG
About this entry
Cite this entry
El-Mallakh, R.S., Belmaker, R.H. (2023). Bipolar Disorder. In: Tasman, A., et al. Tasman’s Psychiatry. Springer, Cham. https://doi.org/10.1007/978-3-030-42825-9_19-1
Download citation
DOI: https://doi.org/10.1007/978-3-030-42825-9_19-1
Received:
Accepted:
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-42825-9
Online ISBN: 978-3-030-42825-9
eBook Packages: Springer Reference MedicineReference Module Medicine